Role of Systemic and Mucosal Immune Responses in Reciprocal Protection against Bordetella pertussis and Bordetella parapertussis in a Murine Model of Respiratory Infection
Open Access
- 1 February 2003
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (2) , 733-738
- https://doi.org/10.1128/iai.71.2.733-738.2003
Abstract
The roles of systemic humoral immunity, cell-mediated immunity, and mucosal immunity in reciprocal protective immunity against Bordetella pertussis and Bordetella parapertussis were examined by using a murine model of respiratory infection. Passive immunization with serum from mice infected with B. pertussis established protective immunity against B. pertussis but not against B. parapertussis . Protection against B. parapertussis was induced in mice that had been injected with serum from mice infected with B. parapertussis but not from mice infected with B. pertussis . Adoptive transfer of spleen cells from mice infected with B. pertussis or B. parapertussis also failed to confer reciprocal protection. To examine the role of mucosal immunity in reciprocal protection, mice were infected with preparations of either B. pertussis or B. parapertussis , each of which had been incubated with the bronchoalveolar wash of mice that were convalescing after infection with B. pertussis or B. parapertussis . Such incubation conferred reciprocal protection against B. pertussis and B. parapertussis on infected mice. The data suggest that mucosal immunity including secreted immunoglobulin A in the lungs might play an important role in reciprocal protective immunity in this murine model of respiratory infection.Keywords
This publication has 17 references indexed in Scilit:
- Reciprocal Protective Immunity againstBordetella pertussisandBordetella parapertussisin a Murine Model of Respiratory InfectionInfection and Immunity, 2001
- Efficacy of chemically cross-linked antigens for acellular pertussis vaccineVaccine, 2000
- Efficacy of pertussis vaccines consisted of antigens detoxified with tea-leaf catechinsVaccine, 2000
- Evidence of Efficacy of the Lederle/Takeda Acellular Pertussis Component Diphtheria and Tetanus Toxoids and Pertussis Vaccine but Not the Lederle Whole‐Cell Component Diphtheria and Tetanus Toxoids and Pertussis Vaccine AgainstBordetella parapertussisInfectionClinical Infectious Diseases, 1999
- The Filamentous Hemagglutinin ofBordetella parapertussisIs the Major Adhesin in the Phase-Dependent Interaction with NCI-H292 Human Lung Epithelial CellsBiochemical and Biophysical Research Communications, 1998
- The efficacy of a whole cell pertussis vaccine and fimbriae against Bordetella pertussis and Bordetella parapertussis infections in a respiratory mouse modelVaccine, 1998
- A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT VaccinePediatrics, 1998
- Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussisThe Pediatric Infectious Disease Journal, 1994
- Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivityEuropean Journal of Immunology, 1984
- EPIDEMICS OF PARAPERTUSSIS 20 Years' Observations in DenmarkThe Lancet, 1971